Thalidomide

2 trials 1 recruiting LOncology

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

1 Recruiting

1 Completed trials

4 Sponsors

9 Countries

Phase II

Phase II: 2

Sponsors using this IMP

Ceska Myelomova Skupina z.s. 1 Emn Trial Office S.r.l. Impresa Sociale 1 European Myeloma Network B.V. 1 Medical University Of Vienna 1

All trials

2 total

MEMMAT - Medulloblastoma European Multitarget Metronomic Anti-Angiogenic Trial Recruiting

2024-515626-92-00 Phase II 7 countries Medical University Of Vienna
A multicenter, open label, randomized phase II study comparing daratumumab combined with bortezomib-cyclophosphamide-dexamethasone (Dara-VCd… Ended

2024-511781-37-00 Phase II 3 countries Ceska Myelomova Skupina z.s.; Emn Trial Office S.r.l. Impresa Sociale; European …

Showing 1–2 of 2 trials

← All drugs A–Z